• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性阻塞性肺疾病的医疗保健利用情况。在一家健康维护组织中进行的病例对照研究。

Health care utilization in chronic obstructive pulmonary disease. A case-control study in a health maintenance organization.

作者信息

Mapel D W, Hurley J S, Frost F J, Petersen H V, Picchi M A, Coultas D B

机构信息

Epidemiology and Cancer Control Program, University of New Mexico Health Sciences Center, 2325 Camino de Salud NE, Albuquerque, NM 87131-5306, USA.

出版信息

Arch Intern Med. 2000 Sep 25;160(17):2653-8. doi: 10.1001/archinte.160.17.2653.

DOI:10.1001/archinte.160.17.2653
PMID:10999980
Abstract

BACKGROUND

Information about health care utilization and costs among patients with chronic obstructive pulmonary disease (COPD) is needed to improve care and for appropriate allocation of resources for patients with COPD (COPD patients or cases) in managed care organizations.

METHODS

Analysis of all inpatient, outpatient, and pharmacy utilization of 1522 COPD patients continuously enrolled during 1997 in a 172,484-member health maintenance organization. Each COPD case was matched with 3 controls (n = 4566) by age (+/-5 years) and sex. Information on tobacco use and comorbidities was obtained by chart review of 200 patients from each group.

RESULTS

Patients with COPD were 2.3 times more likely to be admitted to the hospital at least once during the year, and those admitted had longer average lengths of stay (4.7 vs 3.9 days; P<.001). Mean costs per case and control were $5093 vs $2026 for inpatient services, $5042 vs $3050 for outpatient services, and $1545 vs $739 for outpatient pharmacy services, respectively (P<.001 for all differences). Patients with COPD had a longer smoking history (49.5 vs 34.9 pack-years; P =.002) and a higher prevalence of smoking-related comorbid conditions and were more likely to use cigarettes during the study period (46.0% vs 13.5%; P<.001).

CONCLUSIONS

Health care utilization among COPD patients is approximately twice that of age- and sex-matched controls, with much of the difference attributable to smoking-related diseases. In this health maintenance organization, inpatient costs were similar to and outpatient costs were much higher than national averages for COPD patients covered by Medicare.

摘要

背景

为了改善慢性阻塞性肺疾病(COPD)患者的护理,并在管理式医疗组织中为COPD患者(COPD患者或病例)合理分配资源,需要了解COPD患者的医疗保健利用情况和费用。

方法

对1997年在一个拥有172484名成员的健康维护组织中持续登记的1522例COPD患者的所有住院、门诊和药房使用情况进行分析。每个COPD病例按年龄(±5岁)和性别与3名对照(n = 4566)进行匹配。通过对每组200名患者的病历审查获取吸烟和合并症信息。

结果

COPD患者在一年中至少住院一次的可能性是对照组的2.3倍,且住院患者的平均住院时间更长(4.7天对3.9天;P <.001)。每个病例和对照的住院服务平均费用分别为5093美元对2026美元,门诊服务为5042美元对3050美元,门诊药房服务为1545美元对739美元(所有差异P <.001)。COPD患者有更长的吸烟史(49.5包年对34.9包年;P =.002),与吸烟相关的合并症患病率更高,且在研究期间更有可能吸烟(46.0%对13.5%;P <.001)。

结论

COPD患者的医疗保健利用率约为年龄和性别匹配对照组的两倍,大部分差异归因于与吸烟相关的疾病。在这个健康维护组织中,COPD患者的住院费用与医疗保险覆盖的全国平均水平相似,门诊费用则远高于全国平均水平。

相似文献

1
Health care utilization in chronic obstructive pulmonary disease. A case-control study in a health maintenance organization.慢性阻塞性肺疾病的医疗保健利用情况。在一家健康维护组织中进行的病例对照研究。
Arch Intern Med. 2000 Sep 25;160(17):2653-8. doi: 10.1001/archinte.160.17.2653.
2
Utilization in COPD: patient characteristics and diagnostic evaluation.慢性阻塞性肺疾病中的应用:患者特征与诊断评估
Chest. 2000 May;117(5 Suppl 2):346S-53S. doi: 10.1378/chest.117.5_suppl_2.346s.
3
The direct medical costs of undiagnosed chronic obstructive pulmonary disease.未确诊慢性阻塞性肺疾病的直接医疗费用。
Value Health. 2008 Jul-Aug;11(4):628-36. doi: 10.1111/j.1524-4733.2007.00305.x. Epub 2008 Jan 8.
4
Impact of roflumilast on exacerbations of COPD, health care utilization, and costs in a predominantly elderly Medicare Advantage population.罗氟司特对慢性阻塞性肺疾病(COPD)急性加重、医疗保健利用及成本的影响:以老年医保优势人群为主的研究
Int J Chron Obstruct Pulmon Dis. 2015 Mar 16;10:565-76. doi: 10.2147/COPD.S79025. eCollection 2015.
5
The economic burden of chronic obstructive pulmonary disease (COPD) in a U.S. Medicare population.美国医疗保险人群中慢性阻塞性肺疾病(COPD)的经济负担。
Respir Med. 2008 Sep;102(9):1248-56. doi: 10.1016/j.rmed.2008.04.009. Epub 2008 Jul 11.
6
Healthcare utilization and costs associated with COPD among SEER-Medicare beneficiaries with NSCLC.监测、流行病学和最终结果计划(SEER)医疗保险受益的非小细胞肺癌(NSCLC)患者中与慢性阻塞性肺疾病(COPD)相关的医疗保健利用和费用
J Med Econ. 2018 Sep;21(9):861-868. doi: 10.1080/13696998.2018.1484370. Epub 2018 Jul 2.
7
Health care utilization and cost among children with asthma who were enrolled in a health maintenance organization.参加健康维护组织的哮喘儿童的医疗保健利用情况和费用
Pediatrics. 1997 Jun;99(6):757-64. doi: 10.1542/peds.99.6.757.
8
Burden of chronic obstructive pulmonary disease in Medicare beneficiaries residing in long-term care facilities.长期护理机构中医疗保险受益人的慢性阻塞性肺疾病负担
Am J Geriatr Pharmacother. 2009 Oct;7(5):262-70. doi: 10.1016/j.amjopharm.2009.11.003.
9
Economic burden prior to COPD diagnosis: a matched case-control study in the United States.慢性阻塞性肺疾病(COPD)诊断前的经济负担:美国一项配对病例对照研究
Respir Med. 2008 Dec;102(12):1744-52. doi: 10.1016/j.rmed.2008.07.009. Epub 2008 Aug 28.
10
History of Asthma in Patients with Chronic Obstructive Pulmonary Disease. A Comparative Study of Economic Burden.慢性阻塞性肺疾病患者的哮喘病史。经济负担的比较研究。
Ann Am Thorac Soc. 2016 Feb;13(2):188-96. doi: 10.1513/AnnalsATS.201508-507OC.

引用本文的文献

1
Medication Non-adherence in Older Adults: Underlying Factors, Potential Interventions and Outcomes.老年人用药依从性:潜在因素、干预措施及结果
Drugs Aging. 2025 Sep 11. doi: 10.1007/s40266-025-01249-7.
2
The prevalence of metabolic syndrome in chronic obstructive pulmonary disease: A systematic review and meta-analysis.慢性阻塞性肺疾病中代谢综合征的患病率:一项系统评价和荟萃分析。
Chron Respir Dis. 2025 Jan-Dec;22:14799731251346194. doi: 10.1177/14799731251346194. Epub 2025 May 26.
3
Factors contributing to hospitalization expenditures for patients with COPD in Yunnan Province, China: a path analysis.
中国云南省 COPD 患者住院费用的影响因素:路径分析。
BMC Health Serv Res. 2024 Nov 28;24(1):1496. doi: 10.1186/s12913-024-11874-4.
4
Comorbidities and mortality among patients with chronic obstructive pulmonary disease.慢性阻塞性肺疾病患者的合并症和死亡率。
BMJ Open Respir Res. 2023 Oct;10(1). doi: 10.1136/bmjresp-2023-001798.
5
Healthcare Utilization in Patients with Chronic Obstructive Pulmonary Disease Discharged from Coronavirus 2019 Hospitalization.慢性阻塞性肺疾病患者出院后对冠状病毒 2019 住院的医疗利用。
Int J Chron Obstruct Pulmon Dis. 2023 Aug 22;18:1827-1835. doi: 10.2147/COPD.S415621. eCollection 2023.
6
Healthcare costs of patients with chronic obstructive pulmonary disease in Denmark - specialist care versus GP care only.丹麦慢性阻塞性肺疾病患者的医疗保健费用 - 专科护理与仅全科医生护理比较。
BMC Health Serv Res. 2022 Mar 28;22(1):408. doi: 10.1186/s12913-022-07778-w.
7
Lifetime burden of disease due to incident tuberculosis: a global reappraisal including post-tuberculosis sequelae.由于发病的结核病导致的终生疾病负担:包括结核后后遗症在内的全球再评估。
Lancet Glob Health. 2021 Dec;9(12):e1679-e1687. doi: 10.1016/S2214-109X(21)00367-3.
8
Co-Occurring Depression and Associated Healthcare Utilization and Expenditure in Individuals with Respiratory Condition: A Population-Based Study.患有呼吸系统疾病的个体中同时存在的抑郁症及其相关的医疗保健利用和支出:一项基于人群的研究。
Pharmacy (Basel). 2021 Sep 25;9(4):157. doi: 10.3390/pharmacy9040157.
9
Management and outcomes of patients with chronic obstructive lung disease and lung cancer in a public healthcare system.慢性阻塞性肺疾病和肺癌患者在公共医疗体系中的管理和结局。
PLoS One. 2021 May 17;16(5):e0251886. doi: 10.1371/journal.pone.0251886. eCollection 2021.
10
A population-based analysis of spirometry use and the prevalence of chronic obstructive pulmonary disease in lung cancer.基于人群的肺癌患者肺活量测定使用情况及慢性阻塞性肺疾病患病率分析。
BMC Cancer. 2021 Jan 5;21(1):14. doi: 10.1186/s12885-020-07719-y.